Immunome Competitors and Similar CompaniesClear all
Immunome's competitors and similar companies include Galectin Therapeutics, TRACON Pharmaceuticals, Tosk and Amolyt Pharma.
 Immunome Immunome is a biotech company focused on cancer immunotherapies fueled by the human immune system. |  Galectin Therapeutics Galectin Therapeutics uses galectin science and drug development to create new therapies for fibrotic diseases and cancer. |  TRACON Pharmaceuticals TRACON Pharmaceuticals is a biopharmaceutical company focused on developing targeted therapies for cancer and macular degeneration. |  Tosk Tosk is a biopharmaceutical company that provides drug development solutions for cancer treatment. |  Amolyt Pharma Amolyt Pharma (formerly known as Alizé Pharma) is a company that specializes in the development of biopharmaceutical drugs, proteins, and peptides for the treatment of metabolic diseases and cancer. | |
Founding Date | Founding Date 2008 | Founding Date 2001 | Founding Date 2006 | Founding Date 2008 | Founding Date 2015 |
Type | Type Public | Type Public | Type Public | Type Private | Type Subsidiary |
Tags | |||||
Locations | Locations Exton, US HQ | Locations Norcross, US HQ | Locations San Diego, US HQ | Locations Mountain View, US HQ Sunnyvale, US | Locations Écully, FR HQ Cambridge, US |
Employees | Employees 264% decrease | Employees 717% increase | Employees 268% increase | Employees 128% decrease | Employees 448% decrease |
Valuation ($) | Valuation ($) 746.5 m | Valuation ($) 155.1 m | Valuation ($) 279.4 k | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $14m (FY, 2023) | Revenue (est.) N/A | Revenue (est.) $12m (FY, 2023) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income ($106.8m) (FY, 2023) | Net income ($41.1m) (FY, 2023) | Net income ($3.6m) (FY, 2023) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 23.8m | Total funding raised N/A | Total funding raised $ 41m | Total funding raised $ 8.6m | Total funding raised $ 93.1m |
For sources of this data, please see the company profile
View Company Profiles
Galectin Therapeutics
HQ
Norcross, US
Employees
7↑ 17% increase
Galectin Therapeutics uses galectin science and drug development to create new therapies for fibrotic diseases and cancer.
View companyTRACON Pharmaceuticals
HQ
San Diego, US
Employees
26↑ 8% increase
TRACON Pharmaceuticals is a biopharmaceutical company focused on developing targeted therapies for cancer and macular degeneration.
View companyTosk
HQ
Mountain View, US
Employees
12↓ 8% decrease
Tosk is a biopharmaceutical company that provides drug development solutions for cancer treatment.
View companyAmolyt Pharma
HQ
Écully, FR
Amolyt Pharma (formerly known as Alizé Pharma) is a company that specializes in the development of biopharmaceutical drugs, proteins, and peptides for the treatment of metabolic diseases and cancer.
View company